Myocarditis risk-benefit balance an issue for COVID-19 booster doses in young males

With booster shots of mRNA vaccine now being proposed against COVID-19 in Australia, questions are being raised about the heart risk of multiple doses, particularly in younger male patients. In the US, the FDA has authorised a third booster dose, to be administered at least six months after completion of the primary series for people ...

Already a member?

Login to keep reading.

© 2021 the limbic